Clot-Busting device trial halted after just one patient
NCT ID NCT05992168
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This trial tested a stent-retriever device to remove blood clots from the lungs in people with acute pulmonary embolism. Only one participant was enrolled before the study was terminated. The goal was to see if the device could reduce heart strain and avoid major complications within 48 hours.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Stent-Retriever device
- What this could lead to
- If successful, this device could offer a new way to quickly remove dangerous blood clots from the lungs, potentially reducing heart strain and complications.
- What could go wrong
- The trial was terminated early with only 1 participant, so results are very limited. The device may not be safe or effective for broader use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PE - PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University People'S Hospital
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.